Rhogam

— THERAPEUTIC CATEGORIES —
  • Immune-mediated blood disorders

Rhogam Generic Name & Formulations

General Description

Rho(D) immune globulin human 300mcg; for IM inj.

See Also

How Supplied

Single-dose syringes—5, 25

Manufacturer

Rhogam Indications

Indications

Preventing Rho(D) sensitization in nonsensitized Rho(D) negative or Du negative patients to the Rho(D) factor, following pregnancy or accidental transfusion.

Rhogam Dosage and Administration

Adult

Each vial or syringe (approx. 300mcg) prevents sensitization to a volume of up to 15mL of Rh positive red blood cells. Administer IM at 28 weeks of gestation, within 72 hours of an Rh incompatible delivery, miscarriage, abortion, or transfusion accident.

Children

See literature.

Rhogam Contraindications

Contraindications

Rho(D) positive patients.

Rhogam Boxed Warnings

Not Applicable

Rhogam Warnings/Precautions

Warnings/Precautions

Pregnancy (Cat.C).

Rhogam Pharmacokinetics

See Literature

Rhogam Interactions

Not Applicable

Rhogam Adverse Reactions

Adverse Reactions

Local reactions.

Rhogam Clinical Trials

See Literature

Rhogam Note

Not Applicable

Rhogam Patient Counseling

See Literature